Zobrazeno 1 - 10
of 493
pro vyhledávání: '"A. Blumsohn"'
Publikováno v:
Drug Safety.
Publikováno v:
Drug Safety
Drug Safety, 2023, 46, pp.615-616. ⟨10.1007/s40264-023-01308-1⟩
Drug Safety, 2023, 46, pp.615-616. ⟨10.1007/s40264-023-01308-1⟩
International audience
Autor:
Alain Braillon, Susan Bewley, Aubrey Blumsohn, Florian Naudet, Jean‐Louis Montastruc, Joel R. Lexchin
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 2022, 88 (5), pp.2447-2448. ⟨10.1111/bcp.15142⟩
British Journal of Clinical Pharmacology, Wiley, 2021, ⟨10.1111/bcp.15142⟩
British Journal of Clinical Pharmacology, 2022, 88 (5), pp.2447-2448. ⟨10.1111/bcp.15142⟩
British Journal of Clinical Pharmacology, Wiley, 2021, ⟨10.1111/bcp.15142⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::850ea55f0f8d04021da9350680c17013
https://hal.science/hal-03513917
https://hal.science/hal-03513917
Autor:
Blumsohn, Aubrey, Dyer, Clare
Publikováno v:
BMJ: British Medical Journal, 2010 Jan 01. 340(7736), 22-23.
Externí odkaz:
https://www.jstor.org/stable/25673581
Autor:
Blumsohn, Aubrey
Publikováno v:
BMJ: British Medical Journal, 2007 Sep . 335(7621), 629-629.
Externí odkaz:
https://www.jstor.org/stable/20507816
Publikováno v:
BMJ: British Medical Journal, 2006 Nov . 333(7578), 1121-1122.
Externí odkaz:
https://www.jstor.org/stable/40700006
Autor:
Aubrey Blumsohn, Alain Braillon
Publikováno v:
The BMJ
Objectives To investigate the regulatory handling of cancer drugs that were granted accelerated approval by the US Food and Drug Administration (FDA) but failed to improve the primary endpoint in post-approval trials and to evaluate the extent to whi
Autor:
Zlotkin, Stanley, Blumsohn, Aubrey
Publikováno v:
BMJ: British Medical Journal, 1999 May . 318(7195), 1417-1417.
Externí odkaz:
https://www.jstor.org/stable/25184722
Publikováno v:
South African Medical Journal; Vol 43, No 8 (1969)
Click on the link to view.